Page 2 - Uma Chigurupati News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Granules India concludes its Covid-19 vaccine drive for its workforce

Granules India concludes its Covid-19 vaccine drive for its workforce
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshUma chigurupatiGranules indiaExecutive directorCovid vaccinationஆந்திரா பிரதேஷ்உமா சிகுருபடிதுகள்கள் இந்தியாநிர்வாகி இயக்குனர்

Paediatric trials of Covaxin may begin in June

Paediatric trials of Covaxin may begin in June ANI | Updated: May 24, 2021 03:06 IST Hyderabad (Telangana) [India], May 24 (ANI): Bharat Biotech may begin paediatric trials of its Covid-19 vaccine Covaxin from June, said the company s Business Development and International Advocacy Head Dr Raches Ella on Sunday. Holding a virtual conversation with members of FICCI Ladies Organisation (FLO) Hyderabad on All About Vaccines, he said that the company expected approval from the World Health Organisation (WHO) for Covaxin by the end of the third or fourth quarter. I am happy that our hard work is paying off well as the vaccine is working well and saving lives. We have this good feeling when we go back home from work each day. We will be soon ramping up our manufacturing capacity to 700 million doses by the end of this year, informed Dr. Raches Ella as a response to a question from a participant.

Andhra pradeshPragnya chigurupatiUma chigurupatiRaches ellaUnion governmentInternational advocacy head dr raches ella onLadies organisationWorld health organisationBusiness developmentBharat biotechInternational advocacy head dr raches ellaAbout vaccinesBharath biotechConsultant breast oncologyOncoplastic surgeonState governments

COVID-19: Covaxin s paediatric trials may begin in June, Bharat Biotech expects WHO approval by end of Q3 or Q4

Highlights Dr Raches exuded confidence that vaccines for kids may get the license in the third quarter of this year We focused on developing the product last year. Now our focus is on ramping up our manufacturing capacity, Kids vaccine trials of Bharath Biotech may get the license in the third quarter of this year, he added Hyderabad: Bharat Biotech is all set to begin paediatric trials of its Covid-19 vaccine Covaxin from June. The company`s Business Development and International Advocacy Head Dr Raches Ella said that the company expected approval from the World Health Organisation (WHO) for Covaxin by the end of the third or fourth quarter, said an ANI report.

Andhra pradeshPragnya chigurupatiUma chigurupatiRaches ellaLadies organisationInternational advocacy head dr raches ellaBusiness developmentWorld health organisationBharat biotechBharath biotechConsultant breast oncologyOncoplastic surgeonPrivate hospitalsPaediatric trials of covaxinCovid 19 vaccineBharat biotech

Paediatric trials of Covaxin may begin in June | India News

HYDERABAD: Bharat Biotech may begin paediatric trials of its Covid-19 vaccine Covaxin from June, said the company s Business Development and International Advocacy Head Dr Raches Ella on Sunday. Holding a virtual conversation with members of FICCI Ladies Organisation (FLO) Hyderabad on All About Vaccines, he said that the company expected approval from the World Health Organisation (WHO) for Covaxin by the end of the third or fourth quarter. I am happy that our hard work is paying off well as the vaccine is working well and saving lives. We have this good feeling when we go back home from work each day. We will be soon ramping up our manufacturing capacity to 700 million doses by the end of this year, informed Dr. Raches Ella as a response to a question from a participant.

Andhra pradeshPragnya chigurupatiUma chigurupatiRaches ellaUnion governmentInternational advocacy head dr raches ella onLadies organisationBusiness developmentWorld health organisationBharat biotechInternational advocacy head dr raches ellaAbout vaccinesBharath biotechConsultant breast oncologyOncoplastic surgeonState governments

Covaxin trail on children: Paediatric trials of Covaxin may begin in June | India News

HYDERABAD: Bharat Biotech may begin paediatric trials of its Covid-19 vaccine Covaxin from June, said the company s Business Development and International Advocacy Head Dr Raches Ella on Sunday. Holding a virtual conversation with members of FICCI Ladies Organisation (FLO) Hyderabad on All About Vaccines, he said that the company expected approval from the World Health Organisation (WHO) for Covaxin by the end of the third or fourth quarter. I am happy that our hard work is paying off well as the vaccine is working well and saving lives. We have this good feeling when we go back home from work each day. We will be soon ramping up our manufacturing capacity to 700 million doses by the end of this year, informed Dr. Raches Ella as a response to a question from a participant.

Andhra pradeshPragnya chigurupatiUma chigurupatiRaches ellaUnion governmentInternational advocacy head dr raches ella onLadies organisationBusiness developmentWorld health organisationBharat biotechInternational advocacy head dr raches ellaAbout vaccinesBharath biotechConsultant breast oncologyOncoplastic surgeonState governments